Erle T. Mast, Executive VP and CFO at Clovis Oncology, Inc. (CLVS), sold 3,000 shares at $80.34 ($239K) on 2015-09-01, disclosed to the SEC on 2015-09-03.
Scheduled sale ($239k) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.39 | 200 | $15K | 6.4% |
| 2 | $78.23 | 400 | $31K | 13.1% |
| 3 | $79.39 | 1,000 | $79K | 33.3% |
| 4 | $80.34 | 1,300 | $104K | 43.8% |
| 5 | $81.07 | 100 | $8K | 3.4% |
| Total | $79.50 avg | 3,000 |
| $239K |
| 100% |
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |